Comments on New DNA & Stool-Based Screening Tests to FDA

This week Fight Colorectal Cancer is providing comments to the FDA as they consider two new screening technologies for colorectal cancer. Below are our opinions and recommendations presented to the Molecular and Clinical Genetics Panel as part of the Medical Devices Advisory Committee. Background: This week, the Food & Drug Administration (FDA) is hosting an advisory committee…  Read More

Seniors and the Screening Loophole

“But doctor, I thought screening for colorectal cancer was covered by Medicare!?” Our seniors are facing policy loophole that lands them with an unexpected bill. In a recent report, Colonoscopy Screening After the Affordable Care Act: Cost Barriers Persist for Medicare Beneficiaries on the colonoscopy copay issue by AARP, there continues to be a debate about what portion of…  Read More

HR 1070: Passing a bill is not for the faint of heart

The current political climate on the Hill requires persistence if we want to make change. The Affordable Care Act (ACA) seeks to improve access to colorectal cancer screening by waiving coinsurance*, copays, and deductibles for many colorectal cancer screening tests. Screening tests include colonoscopies, sigmoidoscopies and fecal occult blood tests (FOBT). This sounds simple in theory,…  Read More

No News Is Not Necessarily Good News – Get Your Stool-Based Screening Results

I’ll admit it. I sometimes don’t follow-up with my doctor’s office if they neglect to call me after a scan or lab work. Against everything inside of me that knows how to be a “good patient” and advocate for myself, I still don’t always call to follow-up. Sometimes I am busy. Sometimes I assume no news…  Read More

CDC's Screening for Colorectal Cancer Infographic

 Source:  Screening for Colorectal Cancer Infographic 

Cancer Survivors: Population Explosion Coming

  You think we’ve made a lot of noise during this Colorectal Cancer Awareness month? We’re only going to get louder. On Monday morning, Fight Colorectal Cancer survivors and advocates will ring the opening bell on NASDAQ—representing 1.2 million colorectal cancer survivors in the U.S. who are only going to get louder as our numbers grow.…  Read More